These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36898916)

  • 1. Survival benefit of breast-conserving surgery with adjuvant radiotherapy for young women with ductal carcinoma in situ: A population-based cohort study.
    Tang J; Wang J; Zhang D; Pan X
    Asian J Surg; 2023 Aug; 46(8):3173-3175. PubMed ID: 36898916
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician's Dilemma.
    Shah C; Vicini F
    Ann Surg Oncol; 2023 Oct; 30(11):6281-6283. PubMed ID: 37280311
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.
    Fisher ER
    CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipsilateral breast tumor recurrence after breast-conserving surgery for ductal carcinoma in situ.
    Fujita T
    Ann Surg; 2011 Jun; 253(6):1233; author reply 1233-4. PubMed ID: 21522008
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
    Mulliez T; De Ridder M
    Lancet; 2023 Jan; 401(10370):23-24. PubMed ID: 36610767
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.
    Rourke LL; Hunt KK
    Ann Surg; 2010 Apr; 251(4):592-4. PubMed ID: 20224366
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
    Chua BH; Link EK; Kunkler IH; Olivotto IA
    Lancet; 2023 Jan; 401(10370):24. PubMed ID: 36610769
    [No Abstract]   [Full Text] [Related]  

  • 8. Oncoplastic breast-conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single-center experience.
    Crown A; Carlson E; Rocha FG; Grumley JW
    Breast J; 2020 Dec; 26(12):2391-2394. PubMed ID: 33283376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

  • 10. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
    Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
    Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS).
    Rossi AJ; Verbus EA; Horst K; De Martini W; Allison K; Hernandez JM; Wapnir IL
    Ann Surg Oncol; 2022 Mar; 29(3):1528-1529. PubMed ID: 34471985
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast radiotherapy for ductal carcinoma in situ: could less be more?
    Coles CE; Chatterjee S; Jagsi R; Kirby AM
    Lancet; 2022 Aug; 400(10350):408-410. PubMed ID: 35933995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17].
    Noël G; Proudhom MA; Mazeron JJ
    Cancer Radiother; 1999; 3(4):342-3. PubMed ID: 10486547
    [No Abstract]   [Full Text] [Related]  

  • 18. The problem of ductal carcinoma in situ of the breast.
    Fentiman IS
    Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Can Molecular Diagnostics Add to Locoregional Treatment Recommendations for DCIS?
    Shelley Hwang E; Thompson A
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376162
    [No Abstract]   [Full Text] [Related]  

  • 20. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.